Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2026-02-24 @ 5:45 AM
Study NCT ID:
NCT00994461
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2009-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of Celecoxib In Healthy Subjects
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-13
First Submit QC Date:
None
Study First Post Date:
2009-10-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-22
Results First Submit QC Date:
None
Results First Post Date:
2011-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-29
Last Update Post Date:
2021-02-02
Last Update Post Date Type:
ACTUAL